A Phase 1 interventional study of Opioid in Healthy, sponsored by Grünenthal GmbH. Completed. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2007-07-06.
Sponsored by Grünenthal GmbH · Phase 1, Interventional, and Treatment
The purpose of this study is to demonstrate bioequivalence of a new formulation to a reference
Grünenthal GmbH is the lead sponsor of 68 studies on the registry; 2 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 8 (62%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Bioequivalence acceptance range of 90CI of T/R ratios of AUC and Cmax.
Descriptive, e. g. safety/tolerability of Test comparable to Reference
No study locations are listed for this record.
The record gives a start of Feb 2007 and a completion of Mar 2007. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Analgesics, Opioid